News | June 24, 2011

American Heart Association CEO Praises Graphic Tobacco Warning Labels


June 24, 2011 — American Heart Association (AHA) CEO Nancy Brown praised the new, larger tobacco packaging warning labels unveiled this week by the U.S. Food and Drug Administration (FDA). The labels include graphic images of disease caused by tobacco.

“New cigarette warning labels unveiled today by the Food and Drug Administration will help give us the momentum needed to eradicate tobacco use in our nation,” Brown said. “For the first time in 25 years, cigarette warning labels have been dramatically altered to graphically demonstrate the specific, serious health risks associated with smoking, and these warnings will not only tell smokers how bad tobacco use is, but also direct them to smoking cessation resources that can help them quit.”

According to the Centers for Disease Control and Prevention, more than 45 million Americans smoke cigarettes - about 20 percent of the population - and one in five high school students still smoke. The new health warnings represent an aggressive approach to reducing smoking rates that have leveled off in recent years as tobacco companies continue to launch campaigns to entice new smokers and maintain current customers.

“The American Heart Association strongly believes that the graphic depictions of smoking-related diseases on cigarette packages will drive home the message that tobacco use is an equal opportunity killer, affecting smokers and nonsmokers alike,” Brown said. “In the U.S., about one-third of smoking-related deaths are linked to heart disease and stroke. Cigarette smoking causes about 443,000 premature deaths each year and about 49,000 of these deaths are due to second-hand smoke. Undoubtedly, the new graphic health warnings will heighten awareness about the dangers of smoking and, more importantly, encourage smokers to quit and discourage smoking initiation. We're confident that the new labels will move us closer to our goal of making the nation 100 percent smoke-free.”

For more information: www.heart.org



Related Content

News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...

Home April 08, 2024
Home
News | Cardiovascular Clinical Studies

April 8, 2024 — Taking beta blockers after a heart attack did not significantly reduce the risk of death or a second ...

Home April 08, 2024
Home
Subscribe Now